CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- CorEvitas · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityProspective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
Loading trial locations…
Jeffrey Greenberg, MD
CONTACT